Blood thinners didn t reduce cognitive decline in adults 65 and younger with AFib
In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline, stroke or transient ischemic attack (TIA) in people younger than age 65 who ...
The American Journal of Managed Care56m
From Benefit Status to Transplants, CV Disparities Prove Tough to Tackle
Posters presented at the American Heart Association Scientific Sessions included results that show how persistent disparities ...